source
- Preoperative intravesical mitomycin C cuts NMIBC recurrence risk by 77% over five yearsA recent study evaluated giving two doses of intravesical mitomycin C before transurethral resection of bladder tumor (TURBT) in patients with non‑muscle‑invasive bladder cancer (NMIBC). Compared…
- FDA Commissioner Marty Makary resigns as Biogen unveils new Alzheimer’s dataMarty Makary announced his resignation from the role of FDA commissioner, ending his tenure amid recent political developments. Biogen disclosed fresh data from its Alzheimer’s disease program, ad…